These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22411874)

  • 21. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients.
    Hansen CR; Pressler T; Nielsen KG; Jensen PØ; Bjarnsholt T; Høiby N
    J Cyst Fibros; 2010 Jan; 9(1):51-8. PubMed ID: 19939747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
    De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
    J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doripenem: position in clinical practice.
    Dedhia HV; McKnight R
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):507-14. PubMed ID: 19485791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mediastinitis superinfected by Achromobacter xylosoxidans. A case report.
    Marion-Sanchez K; Lion F; Olive C; Cailleaux G; Roques F
    J Infect Chemother; 2018 Dec; 24(12):987-989. PubMed ID: 29895453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Achromobacter xylosoxidans in two haemodialysis patients.
    Palacios-Gómez ME; Martín-Gómez A; García-Marcos S
    Nefrologia; 2014; 34(4):538-9. PubMed ID: 25036074
    [No Abstract]   [Full Text] [Related]  

  • 26. Perinephric abscess due to Achromobacter xylosoxidans following de-roofing of renal cyst.
    Vinod V; Kumar A; Sanjeevan KV; Dinesh KR; Karim S
    Surg Infect (Larchmt); 2013 Aug; 14(4):422-3. PubMed ID: 23859686
    [No Abstract]   [Full Text] [Related]  

  • 27. JMM Profile:
    Bonis BM; Hunter RC
    J Med Microbiol; 2022 May; 71(5):. PubMed ID: 35587447
    [No Abstract]   [Full Text] [Related]  

  • 28. Complicated intra-abdominal infection caused by extended drug-resistant Achromobacter xylosoxidans.
    Teng SO; Ou TY; Hsieh YC; Lee WC; Lin YC; Lee WS
    J Microbiol Immunol Infect; 2009 Apr; 42(2):176-80. PubMed ID: 19597652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and microbiological evaluation of eight patients with isolated Achromobacter xylosoxidans.
    Atalay S; Ece G; Samlioğlu P; Kose S; Maras G; Gonullu M
    Scand J Infect Dis; 2012 Oct; 44(10):798-801. PubMed ID: 22404460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment with doripenem and tobramycin of ventriculitis due to imipenem- and meropenem-resistant Pseudomonas aeruginosa.
    Gelfand MS; Cleveland KO; Mazumder SA
    J Antimicrob Chemother; 2009 Jun; 63(6):1297-9. PubMed ID: 19369268
    [No Abstract]   [Full Text] [Related]  

  • 32. Achromobacter causing a thrombophlebitis and osteomyelitis combination: a rare cause.
    Pamuk G; Aygun D; Barut K; Kasapcopur O
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26347234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Achromobacter xylosoxidans keratitis masquerading as recurrent erosion after LASIK.
    Riaz KM; Feder RS; Srivastava A; Rosin J; Basti S
    J Refract Surg; 2013 Nov; 29(11):788-90. PubMed ID: 24063345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of hospital-acquired infections due to Achromobacter xylosoxidans in a tertiary care hospital in India.
    Kumar A; Ray P; Kanwar M; Sethi S; Narang A
    J Hosp Infect; 2006 Feb; 62(2):248-50. PubMed ID: 16289456
    [No Abstract]   [Full Text] [Related]  

  • 35.
    Bates AS; Natarajan M; Reddy RV
    BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel bacterium Achromobacter xylosoxidans as a cause of liver abscess: three case reports.
    Asano K; Tada S; Matsumoto T; Miyase S; Kamio T; Sakurai K; Iida M
    J Hepatol; 2005 Aug; 43(2):362-5. PubMed ID: 15978693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Achromobacter xylosoxidans induced bronchiolitis obliterans in cystic fibrosis.
    De Baets F; Schelstraete P; Haerynck F; Van Biervliet S; De Bruyne R; Franckx H; Van Daele S
    Pediatr Pulmonol; 2014 Apr; 49(4):414-6. PubMed ID: 24039244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Achromobacter xylosoxidans colonization in bronchiectasis].
    Sancho-Chust JN; Agudo P; Camarasa A; Chiner E
    Enferm Infecc Microbiol Clin; 2010 Mar; 28(3):203-4. PubMed ID: 19446928
    [No Abstract]   [Full Text] [Related]  

  • 39. Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management.
    Parkins MD; Elborn JS
    J Antimicrob Chemother; 2010 Sep; 65(9):1853-61. PubMed ID: 20605846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sepsis Caused by Achromobacter Xylosoxidans in a Child with Cystic Fibrosis and Severe Lung Disease.
    Stobbelaar K; Van Hoorenbeeck K; Lequesne M; De Dooy J; Ho E; Vlieghe E; Ieven M; Verhulst S
    Am J Case Rep; 2016 Aug; 17():562-6. PubMed ID: 27498677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.